4893 items matching your search terms.

Comorbidity and overall survival in cetuximab-treated patients with advanced colorectal cancer—results from NCIC CTG CO.17: a phase III trial of cetuximab versus best supportive care

Powell, ED Asmis, T Jonker, D Tu, C Karapetis, C Jeffery, M O’Callaghan, C

A randomized, phase III study of carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in relapsed platinum-sensitive ovarian cancer: CALYPSO study of the Gynecologic Cancer Intergroup (GCIG)

Pujade-Lauraine, E Mahner, S Kaern, J Gebski, V Heywood, M Vasey, P Reinthaller, A Vergote, I Pignata, S Ferrero, A

Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial

Rabaglio, M Sun, Z Price, KN Castiglione-Gertsch, M Hawle, H Thurlimann, B Mouridsen, H Campone, M Forbes, JF Paridaens, RJ Colleoni, M Pienkowski, T Nogaret, JM Lang, I Smith, I Gelber, RD Goldhirsch, A Coates, AS
ANNALS OF ONCOLOGY, 2009     DOI:10.1093/annonc/mdp033

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Rajamani, K Colman, PG Li, LP Best, JD Voysey, M D'Emden, MC Laakso, M Baker, JR Keech, AC on behalf of the FIELD study investigators,

Effects of fenofibrate on amputation events in type 2 diabetes mellitus

Rajamani, K Colman, PG Li, LP Best, JD Voysey, M D'Emden, M Laakso, M Baker, J Keech, AD on behalf of the FIELD study investigators,

Effect of fenofibrate on amputation events in people with type 2 diabetes mellitus (FIELD study): a prespecified analysis of a randomised controlled trial

Rajamani, K. Colman, P. G. Li, L. P. Best, J. D. Voysey, M. D'Emden, M. C. Laakso, M. Baker, J. R. Keech, A. C.
THE LANCET, 2009     DOI:10.1016/S0140-6736(09)60698-X

Predictors of lower limb amputation in patients with type 2 diabetes mellitus: the FIELD study

Rajamani, K Li, LP Best, JD Voysey, M D’Emden, M Laakso, M Baker, J Ting, RD Keech, AK on behalf of the FIELD study investigators,

Lower-limb amputation in patients with type 2 diabetes mellitus: factors predicting risk in the FIELD study

Rajamani, K Li, LP Kesaniemi, YA Voysey, M Hunt, D Drury, P D'Emden, MC Colman, PG Taskinen, MR Keech, AC FIELD Study Investigators,

Benchmarking with Spine Tango: potentials and pitfalls

Roeder, C Staub, L Dietrich, D Zweig, T Melloh, M Aebi, M
EUROPEAN SPINE JOURNAL, 2009     DOI:10.1007/s00586-009-0943-7

Cell cycle/apoptosis molecule expression correlates with imatinib response in patients with advanced gastrointestinal stromal tumors

Romeo, S Debiec-Rychter, M Van Glabbeke, M Van Paassen, H Comite, P Van Eijk, R Oosting, J Verweij, J Terrier, P Schneider, U Sciot, R Blay, JY Hogendoorn, PCW on behalf of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group,
CLINICAL CANCER RESEARCH, 2009     DOI:10.1158/1078-0432.ccr-08-3297

Effects of fenofibrate treatment on cardiovascular disease risk in 9795 individuals with type 2 diabetes and various components of the metabolic syndrome: the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Scott, R O'Brien, R Fulcher, G Pardy, C d'Emden, M Tse, D Taskinen, MR Ehnholm, C Keech, A on behalf of the FIELD Study Investigators,
DIABETES CARE, 2009     DOI:10.2337/dc08-1543

Effects of Fenofibrate Treatment on Cardiovascular Disease Risk in 9,795 Individuals With Type 2 Diabetes and Various Components of the Metabolic Syndrome The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study

Scott, R. O'Brien, R. Fulcher, G. Pardy, C. D'Emden, M. Tse, D. Taskinen, M. R. Ehnholm, C. Keech, A.
DIABETES CARE, 2009     DOI:10.2337/dc08-1543

Larger effects of fenofibrate on CVD in marked diabetic dyslipidemia are not explained by higher use of statin therapy: the FIELD study

Simes, RJ Voysey, M O'Connell, R Glasziou, PP Best, JD Scott, R Sullivan, DR Ehnholm, C Keech, AC

Training a new generation of biostatisticians: a successful consortium model

Simpson, J Ryan, P Carlin, JB Gurrin, L Marschner, I for the BCA writing group,

Comparing patients’ and clinicians’ assessment of outcomes in a randomised trial of sentinel node biopsy for breast cancer (the RACS SNAC trial)

Smith, M. J. Gill, P. G. Wetzig, N. Sourjina, T. Gebski, V. Ung, O. Campbell, I. Kollias, J. Coskinas, X. Macphee, A. Young, L. Simes, R. J. Stockler, M. R. Royal Australasian College of Surgeons SNAC Trial Group,